Premium
Successful fertility‐sparing surgery and chemotherapy for stage IC3 ovarian cancer with the postoperative use of the traditional Japanese herbal formulation hachimijiogan: A case report
Author(s) -
Nishio Eiji,
Kawai Satoshi,
Akita Eri,
Fujii Takuma
Publication year - 2017
Publication title -
traditional and kampo medicine
Language(s) - English
Resource type - Journals
ISSN - 2053-4515
DOI - 10.1002/tkm2.1074
Subject(s) - medicine , carboplatin , ovarian cancer , chemotherapy , stage (stratigraphy) , fertility , paclitaxel , ovarian reserve , pregnancy , cancer , gynecology , obstetrics , surgery , cisplatin , population , infertility , paleontology , genetics , environmental health , biology
Case A 32‐year old, unmarried, nulligravida woman was diagnosed as having ovarian cancer stage IC3. The patient received six cycles of carboplatin and paclitaxel every 4 weeks after surgery. She was given a gonadotropin‐releasing hormone agonist as an ovarian safeguard while receiving treatment with anticancer agents. Outcome After treatment with the traditional Japanese herbal formulation hachimijiogan and oral contraceptives, the patient spontaneously became pregnant and gave birth to a healthy baby at 40 gestational weeks. Conclusion A hachimijiogan treatment may be effective for treating decreased ovarian function following chemotherapy.